FDA Clears IotaMotion’s Robotic CI Insertion System for Expanded Pediatric Use
The IotaSoft robotic-assisted cochlear implant insertion system is now cleared for use in children aged four and older.
The IotaSoft robotic-assisted cochlear implant insertion system is now cleared for use in children aged four and older.
Dr Jane Madell reflects on the evolution of pediatric audiology technology and testing methods while emphasizing the enduring importance of early diagnosis, behavioral testing, and fitting children with appropriate devices.
The two draft standards from APSO will cover pediatric hearing evaluation and the intake process of general audiologists.
Children with developmental disabilities—1 in 6 children in the United States—are less likely to access a gold-standard hearing assessment in the first three months of hearing care, a recent paper reported.
Read MoreWe need to increase awareness about testing for cCMV so this cause of non-genetic deafness in newborns can be diagnosed and treated.
Read MoreThe clinical innovation lab is improving the use of 3D printing for custom pediatric hearing aid earmolds to significantly improve efficiency in patient care.
Read MoreUnitedHealthcare has expanded its coverage of cochlear implants to include children as young as 6 months effective Sept. 1, 2024.
Read MoreThe International Pediatric Conference, to be held this October 2024, will bring together global experts to discuss childhood hearing loss.
Read MoreThe ADHS and the Arizona Commission for the Deaf and the Hard of Hearing received a grant to enhance early pediatric hearing screening.
Read MoreThe plan aims to enhance access to pediatric audiology and Listening and Spoken Language services for children who are deaf or hard of hearing.
Read MoreThe HEAR program is a text messaging service supporting families of children with hearing loss through expert advice and community connection.
Read MoreWhile it’s not surprising to spot teens wearing headphones and earbuds, it’s also becoming a widespread trend among younger children, a national poll suggests.
Read MoreA look at advancements in pediatric hearing aids and advice to enhance the fitting experience for younger patients and their HCPs.
Read MoreThe clinical trial will test a gene therapy drug to treat children with a form of hereditary deafness caused by mutations in the OTOF gene.
Read MoreResearchers found the novel gene therapy to be an effective treatment for patients with a specific form of autosomal recessive deafness.
Read MoreTemporary hearing loss from ear infections can lead to deficits in auditory processing and language development in children years later.
Read MoreAccording to the legislation, coverage includes one hearing aid per ear, up to a cost of $1,500, every 24 months.
Read MoreAcclarent received FDA clearance for its pediatric Eustachian Tube Balloon Dilation System in the treatment of children.
Read More